{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-024462","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.761965+00:00","generated_at":"2026-06-21T22:44:00.506392+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arcadia Biosciences Q3 revenue down 21% YoY to $1.9M; GoodWheat hits 1,000 stores","bullets":["Q3 2022 revenue $1.9M vs $2.4M in Q3 2021, driven by lower body care/GLA, partly offset by GoodWheat pasta.","Gross margin improved to 28% (cost of revenues $1.3M); operating expenses cut 42% to $6.5M.","Net loss attributable to common stockholders $2.9M ($0.12 per share) vs $2.2M ($0.10) in Q3 2021.","GoodWheat pasta distribution doubled from Q2 to ~1,000 stores, reaching year-end goal early.","Company streamlined operations by divesting Saavy Naturals brand and manufacturing facility."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-024462","json":"https://secwatch.observer/filing/0000950170-22-024462.json","markdown":"https://secwatch.observer/filing/0000950170-22-024462.md","text":"https://secwatch.observer/filing/0000950170-22-024462.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022024462/0000950170-22-024462-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022024462/rkda-20221110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T22:44:00.506392+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"874afbd3d2c7584ac2b8c1a6b3438332f99c430a","claim":"Arcadia Biosciences, Inc. reported the third quarter ended September 30, 2022 results: revenue $1.9 million, net income $2.9 million, EPS $0.12 per share.","evidence_excerpt":"are included in the Form 8-K filed today, available in the Investors section of the company’s website under SEC Filings . 1 Revenues In the third quarter of 2022, revenues were $1.9 million, compared to $2.4 million in the third quarter of 2021 – a $498,000 decrease driven primarily by lower body care and GLA revenue, partially offset by GoodWheat pasta sales.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022024462/0000950170-22-024462-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Revenue","value":"$1.9 million"},{"label":"Net income","value":"$2.9 million"},{"label":"EPS","value":"$0.12 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}